Significant rate changes in CMS’s Q4 ASP drug pricing
Despite very few new or removed codes, you will see some sharp up and down price changes for many of the top billed drug codes in CMS’s Average Sales Price (ASP) list for the fourth quarter. Drug prices remain relatively stable and prices for the top Part B drugs increased by1.5% on average, a 0.7% increase from last quarter.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.